Increased Id-1 expression is significantly associated with poor survival of patients with prostate cancer

Human Pathology

Volumn 38, Issue 9, 2007, Pages 1321-1329

  Forootan, Shiva S ^a   Wong, Yong Chuan ^b   Dodson, Andrew ^a   Wang, Xianghong ^b   Lin, Ke ^a   Smith, Paul H ^a   Foster, Christopher S ^a   Ke, Youqiang ^a  

^a Faculty of Medicine   (United Kingdom)

^b Faculty of Medicine   (Hong Kong)

Author keywords

Gleason scores; Id 1; Prognosis; Prostate cancer; PSA; Survival

Indexed keywords

ANDROGEN RECEPTOR; INHIBITOR OF DIFFERENTIATION 1; PROSTATE SPECIFIC ANTIGEN;

AGED; ARTICLE; CANCER EPIDEMIOLOGY; CANCER SURVIVAL; CONTROLLED STUDY; GLEASON SCORE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; MALE; PROSTATE CANCER; PROSTATE CARCINOMA; PROSTATE HYPERTROPHY; PROTEIN EXPRESSION; WESTERN BLOTTING;

BLOTTING, WESTERN; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; INHIBITOR OF DIFFERENTIATION PROTEIN 1; KAPLAN-MEIERS ESTIMATE; MALE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 34547842098     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2007.02.011     Document Type: Article

References (41)

1. Landis S.H., Murray T., Bolden S., and Wingo P.A. Cancer statistics. CA Cancer J Clin 49 (1999) 8-31
2. Foster C.S., Cornford P., Forsyth L., Djamgoz M.B., and Ke Y. The cellular and molecular basis of prostate cancer. BJU International 83 (1999) 171-194
3. Adamson J., Morgan E., Beesley C., et al. High-level expression of cutaneous fatty acid-binding protein in prostatic carcinomas and its effect on tumorigenicity. Oncogene 22 (2003) 2739-2749
4. Jing C., Beesley C., Foster C., et al. Human cutaneous fatty acid-binding protein induces metastasis by up-regulating the expression of vascular endothelial growth factor gene in rat Rama 37 model cells. Cancer Res 61 (2001) 4357-4364
5. Jing C., El-Ghany M.A., Beesley C., et al. Tazarotene-induced gene 1 (TIG1) expression in prostate carcinomas and its relationship to tumorigenicity. J Natl Cancer Inst 94 (2002) 482-490
6. Perk J., Iavarone A., and Benezra R. Id family of helix-loop-helix proteins in cancer. Nat Rev Cancer 5 (2005) 603-614
7. Mathew S., Chen W., Murty V.V., Benezra R., and Chaganti R.S. Chromosomal assignment of human ID1 and ID2 genes. Genomics 30 (1995) 385-387
8. Deed R.W., Hirose T., Mitchell E.L., Santibanez-Koref M.F., and Norton J.D. Structural organisation and chromosomal mapping of the human Id-3 gene. Gene 151 (1994) 309-314
9. Pagliuca A., Bartoli P.C., Saccone S., Della Valle G., and Lania L. Molecular cloning of ID4, a novel dominant negative helix-loop-helix human gene on chromosome 6p21.3-p22. Genomics 27 (1995) 200-203
10. Bain G., Cravatt C.B., Loomans C., Alberola-Ila J., Hedrick S.M., and Murre C. Regulation of the helix-loop-helix proteins, E2A and Id3, by the Ras-ERK MAPK cascade. Nat Immunol 2 (2001) 165-171
11. Tournay O., and Benezra R. Transcription of the dominant-negative helix-loop-helix protein Id-1 is regulated by a protein complex containing the immediate-early response gene Egr-1. Mol Cell Biol 16 (1996) 2418-2430
12. Hara E., Hall M., and Peters G. Cdk2-dependent phosphorylation of Id2 modulated activity of E2A-related transcription factors. EMBO J 16 (1997) 332-342
13. Lyden D., Young A., Zagzag D., et al. Id1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts. Nature 401 (1999) 670-677
14. Lin C.Q., Singh J., Murata K., et al. A role for Id-1 in the aggressive phenotype and steroid hormone response of human breast cancer cells. Cancer Res 60 (2000) 1332-1340
15. Schindl M., Oberhuber G., Obermair A., Schoppmann S., Karner B., and Birner P. Overexpression of Id-1 protein is a marker for unfavorable prognosis in early-stage cervical cancer. Cancer Res 61 (2001) 5703-5706
16. Ouyang X.S., Wang X., Lee D.T., Tsao S.W., and Wong Y.C. Over expression of ID-1 in prostate cancer. J Urol 167 (2002) 2598-2602
17. Wang Q., Tsao S.W., Fu S., et al. Overexpression of Id-1 in gastric adenocarcinoma: implication for a novel diagnostic marker. Anticancer Res 24 (2004) 881-886
18. Matsuda Y., Yamagiwa S., Takamura M., et al. Overexpressed Id-1 is associated with a high risk of hepatocellular carcinoma development in patients with cirrhosis without transcriptional repression of p16. Cancer 104 (2005) 1037-1044
19. Swarbrick A., Akerfeldt M.C., Lee C.S., et al. Regulation of cyclin expression and cell cycle progression in breast epithelial cells by the helix-loop-helix protein Id1. Oncogene 24 (2005) 381-389
20. Berthon P., Cussenot O., Hopwood L., Le Duc A., and Maitland N.J. Functional expression of SV40 in normal human prostatic epithelial and fibroblastic cells: differentiation pattern of non-tumorigenic cell lines. Int J Oncol 6 (1995) 333-343
21. Cussenot O., Berthon P., Berger R., et al. Immortalization of human adult normal prostatic epithelial cells by liposomes containing Large T-SV40 gene. J Urol 146 (1991) 881-886
22. Horoszewicz J.S., Leong S.S., and Kawinski E. LNCaP model of human prostatic carcinoma. Cancer Res 43 (1983) 1809-1818
23. Stone K.R., Mickey D.D., Wunderli H., Mickey G.H., and Paulson D.F. Isolation of human prostate carcinoma cell line (Du-145). Int J Cancer 21 (1978) 274-281
24. Kaighn M.E., Lechner J.F., Narayan K.S., and Jones L.W. Prostate carcinoma: tissue culture cell lines. Natl Cancer Inst Monogr 49 (1978) 17-21
25. Ke Y., Jing C., Barraclough R., Smith P., Davies M.P.A., and Foster C.S. Elevated expression of calcium-binding protein p9ka is associated with increasing malignant characteristics of rat prostate carcinoma cells. Int J Cancer 71 (1997) 827-837
26. Forootan S.S., Foster C.S., Aachi V.R., et al. Prognostic significance of osteopontin expression in human prostate cancer. Int J Cancer 118 (2006) 2255-2261
27. Deshmukh N., Scotson J., Dodson A., Ke Y., and Foster C.S. Differential expression of acidic and basic fibroblast growth factor in benign prostatic hyperplasia identified by immunohistochemistry. Br J Urol 80 (1997) 869-874
28. Ito K., Yamamoto T., Ohi M., Kurokawa K., Suzuki K., and Yamanaka H. Free/total PSA ratio is a powerful predictor of future prostate cancer morbidity in men with initial PSA levels of 4.1 to 10 ng/ml. Urology 61 (2003) 760-764
29. Yuen H., Chua C., Chan Y., Wong Y., Wang X., and Chan K. Id protein expression in prostate cancer: high-level expression of Id-4 in primary prostate cancer is associated with development of metastasis. Mod Pathol 19 (2006) 931-941
30. Li R., Wheeler T., Dai H., Frolov A., Thompson T., and Ayala G. High level of androgen receptor is associated with aggressive clinicopathologic features and decreased biochemical recurrence-free survival in prostate. Am J Surg Pathol 28 (2004) 928-934
31. Gleason D.F., and Mellinger G. Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging. J Urol 111 (1974) 58-64
32. Ling M., Lau T.C., Zhou C., et al. Overexpression of Id-1 in prostate cancer cells promotes angiogenesis through the activation of vascular endothelial growth factor (VEGF). Carcinogenesis 26 (2005) 1668-1676
33. Al-Hajj M., and Clarke M.F. Self-renewal and solid tumour stem cells. Oncogene 23 (2004) 7274-7282
34. Hara E., Yamaguchi T., Nojima H., et al. Id-related genes encoding helix-loop-helix proteins are required for G1 progression and are repressed in senescent human fibroblasts. J Biol Chem 269 (1994) 2139-2145
35. Fong S., Itahana Y., Sumida T., et al. Id-1 as a molecular target in therapy for breast cancer cell invasion and metastasis. Proc Natl Acad Sci U S A 100 (2003) 13543-13548
36. Minn A., Gupta G., Siegel P., et al. Genes that mediate breast cancer metastasis to lung. Nature 436 (2005) 518-524
37. Zhang X., Ling M.T., Wang X., and Wong Y.C. Inactivation of Id-1 in prostate cancer cells: a potential therapeutic target in inducing chemosensitization to taxol through activation of JNK pathway. Int J Cancer 118 (2006) 2072-2081
38. Coppe J.P., Itahana Y., Moore D.H., Bennington J.L., and Desprez P.Y. Id-1 and Id-2 proteins as molecular markers for human prostate. Clin Cancer Res 10 (2004) 2044-2051
39. Stanbrough M., Leav I., Kwan P.W., Bubley G.J., and Balk S.P. Prostatic intraepithelial neoplasia in mice expressing an androgen receptor transgene in prostate epithelium. Proc Natl Acad Sci U S A 98 (2001) 10823-10828
40. Shah R.B., Mehra R., Chinnaiyan A.M., et al. Androgen-independent prostate cancer is a heterogeneous group of disease: lessons from a rapid autopsy program. Cancer Res 64 (2004) 9209-9216
41. Asirvatham A.J., Schmidt M., Gao B., and Chaudhary J. Androgens regulate the immune/inflammatory response and cell survival pathways in rat ventral prostate epithelial cells. Endocrinology 147 (2006) 257-271